| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544684 Hydrazono-malonitriles |
| 06/09/2009 | US7544669 Polynucleotide therapy |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544361 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration |
| 06/09/2009 | US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | CA2382886C Benzamide formulation with histone deacetylase inhibitor activity |
| 06/09/2009 | CA2382037C Grape seeds, cold-pressed grape seed oil, crushed grape seeds and grape seed meal |
| 06/09/2009 | CA2317443C Agent for treating allergic or hypersensitivity condition |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/04/2009 | WO2009070118A1 Novel wheat allergens |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069448A1 Adjuvant for japanese b encephalitis vaccine, and japanese b encephalitis vaccine |
| 06/04/2009 | WO2009069447A1 Adjuvant for influenza vaccine, and influenza vaccine |
| 06/04/2009 | WO2009069355A1 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 06/04/2009 | WO2009068997A1 Use of a l. casei strain, for the preparation of a composition for inhibiting mast cell activation |
| 06/04/2009 | WO2009068996A2 Conjugated beta-1,3-linked glucans |
| 06/04/2009 | WO2009068798A1 Compositions based on positively-charged cyclodextrins for preserving cells, tissues and organs, method for obtaining same and uses thereof |
| 06/04/2009 | WO2009068682A2 Phenyl-oxetanyl-derivatives |
| 06/04/2009 | WO2009068615A1 Ex vivo method for producing a preparation containing cd4+ t cells specific for ebv structural antigens |
| 06/04/2009 | WO2009068575A1 Compositions for treating an intestinal inflammatory condition |
| 06/04/2009 | WO2009068482A1 Amino triazoles as pi3k inhibitors |
| 06/04/2009 | WO2009052489A3 Novel inhibitors of mammalian tight junction opening |
| 06/04/2009 | WO2009052081A3 Antibodies that bind il-4 and/or il-13 and their uses |
| 06/04/2009 | WO2009042711A4 Polo-like kinase inhibitors |
| 06/04/2009 | WO2009040022A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009037439A3 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3 |
| 06/04/2009 | WO2009033815A3 Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent |
| 06/04/2009 | WO2009033734A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009033657A3 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents |
| 06/04/2009 | WO2009027753A4 Composition and method inhibiting inflammation |
| 06/04/2009 | WO2009022216A3 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 06/04/2009 | WO2008139262A3 Oligoribonucleotides and uses thereof |
| 06/04/2009 | US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same |
| 06/04/2009 | US20090143416 Method of Inducing Tolerance of Plants Against Bacterioses |
| 06/04/2009 | US20090143400 Purine derivatives having immuno-modulating properties |
| 06/04/2009 | US20090143372 Chemical compounds |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/04/2009 | US20090143354 P2X7 Receptor Antagonists and Their Use |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090143292 Liquid Formulation of G-CSF Conjugate |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142377 Immunogenic compositions |
| 06/04/2009 | US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 06/04/2009 | US20090142373 Immunizing Against HIV Infection |
| 06/04/2009 | US20090142372 Therapeutic composition for use in the prevention and treatment of bone metastases |
| 06/04/2009 | US20090142368 Chemically Programmable Immunity |
| 06/04/2009 | US20090142365 Compositions and methods for using ca9 protein to stimulate an immune response |
| 06/04/2009 | US20090142356 Pharmaceutical Composition of F(ab')2 Antibody Fragments and a Process for the Preparation Thereof |
| 06/04/2009 | US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142320 METHOD TO MINIMIZE IL-17 PRODUCTION DURING nTREG CELL EXPANSION |
| 06/04/2009 | US20090142301 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
| 06/04/2009 | US20090142297 5-substituted isoindoline compounds |
| 06/04/2009 | US20090142295 Anti-Connexin Compounds and Uses Thereof |
| 06/04/2009 | DE19549852B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |
| 06/04/2009 | DE102008053348A1 Medicament useful for suppressing the immune system, treating necrotic cell death, ischemia, hypoxia, trauma, diabetes mellitus, myocardial infarction and/or cerebral ischemia, and treating the patients after resustication |
| 06/04/2009 | CA2707190A1 Novel wheat allergens |
| 06/04/2009 | CA2707095A1 Phenyl-oxetanyl-derivatives |
| 06/04/2009 | CA2706620A1 Conjugated beta-1,3-linked glucans |
| 06/04/2009 | CA2706578A1 Amino triazoles as pi3k inhibitors |
| 06/04/2009 | CA2706429A1 Compositions for treating an intestinal inflammatory condition |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |
| 06/03/2009 | EP2065462A1 Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065396A1 Interleukin-19 |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP2065048A1 Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation |
| 06/03/2009 | EP2065040A2 Sphingolipids against pathological processes in lipid rafts |
| 06/03/2009 | EP2064242A1 Engineered anti-il-23p19 antibodies |
| 06/03/2009 | EP2064214A1 Pyraz0l0(l,5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors |
| 06/03/2009 | EP2064212A1 Pyrrolo isoquinolines as kinase inhibitors |
| 06/03/2009 | EP2064207A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 06/03/2009 | EP2063908A2 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 06/03/2009 | EP1435906B1 Method for producing biologically active products |
| 06/03/2009 | EP1399440B1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 06/03/2009 | EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | EP0833649B2 Methods of preventing or treating allergies |
| 06/03/2009 | EP0772677B1 T cell activation |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101444624A Medicine for cancer therapy |
| 06/03/2009 | CN101444509A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/02/2009 | US7541443 A humanized antibody for use as immunosuppressants, treating or preventing transplant rejection in human patient; drug screening |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541376 3-(3-Fluoro-phenyl)-6-methoxy-1H-indazole-5-carboxylic acid(furan-2-ylmethyl)-amide; 3-Benzo[b]thiophen-2-yl-4-methoxy-1H-indazole-5-carboxylic acid[3-(2-oxo-pyrrolidin-1-yl)-propyl]-amide; Jun amino-terminal kinase (JNK) inhibitor; immunologic disease, inflammatory and neurodegenerative diseases |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541354 Bicyclo-pyrazoles |
| 06/02/2009 | US7541350 Formulation containing anti-inflammatory androstane derivative |
| 06/02/2009 | US7541334 Hybrid peptides modulate the immune response |
| 06/02/2009 | US7541328 Coupling proteins to a modified polysaccharide |